REG - JPMorgan Emerg. EMEA - Directorate Change

JPMorgan Emerging Europe Middle East & Africa SecuritiesAnnouncement

19/06/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240619:nRSS9537Sa&default-theme=true

RNS Number : 9537S  JPMorgan Emerging EMEA Securities  19 June 2024

 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC

(the 'Company')

 

Directorate Change

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

Information disclosed in accordance with Listing Rule 9.6.11

 

The Board of JPMorgan Emerging Europe Middle East & Africa Securities plc
(the "Company") is pleased to announce the appointment of Yulia Chekunaeva as
an independent Non-executive Director of the Company with effect from 1(st)
July 2024.  The appointment was made after a thorough selection process
undertaken with the assistance of a third party independent search
consultancy.

Yulia Chekunaeva has extensive senior executive experience in the emerging
markets industrials sectors at EN+ Group IPJSC London, Goldman Sachs London
and Sberbank of Russia, CIB.  She was until 2022 a Non-executive Director of
NordGold plc.

Yulia Chekunaeva does not currently hold any shares in the Company. No further
information is to be disclosed in respect of paragraphs 9.6.13 (2) - (6) of
the Financial Conduct Authority's Listing Rules for Yulia Chekunaeva.

Commenting on the above event, Eric Sanderson, the Company's Chairman, said:

"I am confident that Yulia Chekunaeva will make an excellent addition to the
Board offering a blend of skills and experience that matches well with the
Company's portfolio of investments."

 

JPMorgan Funds
Limited

Company Secretary

19(th) June 2024

 

For further information, please contact:

JPMorgan Funds Limited

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPUAAQUPCGMR